A dose-response study of propranolol in chronic schizophrenics.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000328:Adult; D001007:Anxiety / Q000188:drug therapy; D001519:Behavior / Q000187:drug effects; D001786:Blood Glucose; D001794:Blood Pressure / Q000187:drug effects; D002118:Calcium / Q000097:blood; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007360:Intelligence / Q000187:drug effects; D007773:Lactates / Q000097:blood; D008297:Male; D008875:Middle Aged; D011433:Propranolol / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000188:drug therapy; D012559:Schizophrenia / Q000188:drug therapy*
D000319:Adrenergic beta-Antagonists; D001786:Blood Glucose; D007773:Lactates; D011433:Propranolol; D002118:Calcium